logo-loader
RNS
Transense Technologies

Transense Technlgy - Grant of Options

RNS Number : 0399E
Transense Technologies PLC
13 May 2026
 

Transense Technologies plc

("Transense" or the "Company")

 

 Grant of share options

 

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement systems, announces that on 12 May 2026, the Company's remuneration committee (the "Remuneration Committee") approved the grant of 100,000 share options (the "Options") to acquire ordinary shares of 10 pence each in the Company ("Ordinary Shares") to Ryan Maughan, the Company's Managing Director.

 

In accordance with the Company's share scheme, the Options are subject to performance criteria and have an exercise price of 10 pence per share, being nominal value, and can be exercised after three years until the tenth anniversary of the grant. Two thirds of the Options are exercisable if the Company's share price reaches or exceeds 150 pence per share for ten consecutive trading days at any time, and no Options are exercisable unless this is achieved. The remaining third are exercisable, in full, if the share price reaches or exceeds 200 pence per share for ten consecutive trading days at any time. None of this tranche is exercisable if the share price has not reached 150 pence per share for ten consecutive trading days and a pro‐rata amount will be exercisable between these two share price targets. 

 

Following this grant, Ryan Maughan is now interested in a total of 450,000 share options in the Company.

 

205,000 additional Options have been granted to other employees on the same basis. Following these grants, the Company has a total of 1,895,000 options outstanding, representing approximately 11.53% of the Company's issued share capital.

 

The Company's remuneration policy approved by shareholders by an advisory vote at the Annual General Meeting in November 2024 permits overall headroom for the grant of share options of 15% of the issued share capital in any ten year period. 

 

For further information please visit https://www.transense.com or contact:

 

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

 

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software, and a growing list of international territory distribution partners.

In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

 

Find out more at: https://www.transense.com/ 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ryan Maughan

2

 

Reason for the notification

a)

 

Position/status

 

Managing Director

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

Transense Technologies plc

b)

 

LEI

 

2138005N52J6KKQ3EY67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Options over Ordinary shares of 10 pence each



Identification code

GB00BDHDTH21



b)

 

Nature of the transaction 

 

Grant of options

c)

Price and volume

Exercise Price(s) 10p

Volume(s) 100,000

d)

 

Aggregated information




- Aggregated volume

As above



- Price




e)

 

Date of the transaction

 

12 May 2026

f)

 

Place of the transaction

 

Outside a trading venue

 

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFEEDIFLIR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read